It hopes to turn around Ranbaxy within four years of closing the deal by improving efficiency and resolving all regulatory issues
Raj Barathur -- Indian American entrepreneur, geneticist, professor and biopharmaceutical industry leader -- stayed the course even when diagnosed with lung cancer
Sensex climbs higher on favourable global cues.
Experts prefer domestic consumption-driven plays and defensives such as information technology and pharmaceuticals
It's difficult to understand if GDP growth has actually improved.
Benchmark share indices ended lower for the third straight session as investors turned cautious amid tensions in Iraq even as consumer durables shares stole the limelight tracking rally in gold prices.
Rate sensitive sectors rallied the most led by banks while metals surged on rebound in commodity prices
India Inc had cheered Donald Trump's decision to scrap TPP, but now there is a growing sense that it won't really lead to positive growth in trade with the US. Subhayan Chakraborty reports.
USL is already contesting a Karnataka High Court order.
Mumbai-based serial entrepreneur Shreekant Pawar, who is all set to launch a device to help fight diabetes tells us more about the lessons he's learned in the journey
Apple has not divulged much specific detail on HealthKit, which is expected to be incorporated into the iPhone 6 come September.
Sensex ended above 26,000 led by telecom shares amid TRAI's spectrum sharing norms.
Rediff.com digs into its archives, tracking down Dr M R Rajagopal's sincere efforts of changing lives and changing the way India looks at palliative care.
T N Ninan lists a few David-Goliath encounters in the Indian markets, all of which make life interesting, though difficult if you are an investor looking for the next multi-bagger.
